Skip to main content
. 2021 Jun 30;9(7):708. doi: 10.3390/vaccines9070708

Figure 2.

Figure 2

IgGSP levels in naïve subjects and LT patients after 2 doses of COVID-19 vaccine. NA2D, naïve subjects (non-transplanted and not had previous SARS-CoV-2 infection) after 2 doses of vaccine; TA2D, LT patients after 2 doses of vaccine; thick red line, median value.